| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
42,181 |
32,689 |
$2.11M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,149 |
4,087 |
$369K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,610 |
3,512 |
$327K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,427 |
6,845 |
$306K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
20,099 |
9,102 |
$305K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,071 |
2,876 |
$254K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,093 |
2,045 |
$193K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,321 |
2,168 |
$184K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,840 |
11,021 |
$169K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,976 |
3,766 |
$112K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,495 |
1,449 |
$108K |
| 99050 |
|
8,996 |
7,972 |
$97K |
| 90670 |
|
2,059 |
1,959 |
$86K |
| 99499 |
|
1,181 |
1,059 |
$82K |
| 90461 |
|
5,041 |
4,136 |
$50K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,277 |
2,748 |
$41K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,720 |
2,632 |
$37K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
612 |
529 |
$32K |
| 90651 |
|
888 |
869 |
$23K |
| 90681 |
|
1,171 |
1,104 |
$19K |
| 99381 |
|
172 |
164 |
$17K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,428 |
1,254 |
$16K |
| 99460 |
|
250 |
218 |
$14K |
| 90700 |
|
1,437 |
1,409 |
$14K |
| 90686 |
|
3,321 |
3,228 |
$12K |
| 99051 |
|
350 |
317 |
$11K |
| 99383 |
|
53 |
52 |
$7K |
| 90713 |
|
611 |
596 |
$7K |
| 0071A |
|
166 |
163 |
$6K |
| 90633 |
|
1,342 |
1,318 |
$6K |
| 0072A |
|
159 |
155 |
$6K |
| 90648 |
|
1,389 |
1,345 |
$6K |
| 99429 |
|
186 |
176 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
39 |
38 |
$5K |
| 90716 |
|
327 |
321 |
$5K |
| 99384 |
|
30 |
30 |
$4K |
| 90619 |
|
344 |
341 |
$4K |
| 96160 |
|
1,804 |
1,744 |
$4K |
| 90734 |
|
168 |
161 |
$4K |
| 90620 |
|
280 |
268 |
$3K |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
132 |
119 |
$3K |
| 90707 |
|
319 |
314 |
$3K |
| 81002 |
|
834 |
792 |
$2K |
| 90715 |
|
263 |
252 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
12 |
$956.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,577 |
1,455 |
$686.98 |
| 90744 |
|
153 |
144 |
$673.47 |
| 90677 |
|
446 |
436 |
$577.32 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
362 |
262 |
$522.27 |
| 90710 |
|
700 |
678 |
$322.86 |
| 90685 |
|
13 |
13 |
$264.42 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
77 |
75 |
$172.13 |
| 96127 |
|
70 |
68 |
$37.73 |
| 90723 |
|
448 |
420 |
$0.42 |
| 90696 |
|
251 |
246 |
$0.16 |
| 90697 |
|
714 |
665 |
$0.10 |
| 91307 |
|
325 |
297 |
$0.07 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
76 |
35 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
24 |
18 |
$0.00 |